Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
117.41
Nov 12 • 3:59 PM ET Dollar change-5.72 Percentage change(-4.65%)
Aftermarket Close
117.10
Aftermarket • 7:30 PM ET Dollar change-0.31 Percentage change(-0.26%)
Category
Equity - Leveraged / Inverse
Sponsor
ProShares
Fund Family
Index
Nasdaq Biotech Index
Index Weighting
Active/Passive
Expense
0.95%
Inverse/Leveraged
IPO
Apr 08, 2010
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
0.86%
SMA50
3.30%
SMA200
21.71%
Return% 1Y
72.75%
Return% 3Y
40.83%
Return% 5Y
5.13%
Return% 10Y
Return% SI
Flows% 1M
4.40%
Flows% 3M
7.08%
Flows% YTD
-10.02%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
255
AUM
108.31M
NAV/sh
52W High
126.40 -7.11%
52W Low
73.12 60.57%
Volatility
3.67% 3.72%
ATR (14)
5.10
RSI (14)
51.13
Beta
1.24
Rel Volume
0.63
Avg Volume
9.74K
Volume
6,119
Perf Week
4.21%
Perf Month
9.91%
Perf Quarter
9.86%
Perf Half Y
38.49%
Perf YTD
47.17%
Perf Year
54.34%
Perf 3Y
181.28%
Perf 5Y
36.97%
Perf 10Y
148.43%
Prev Close
123.13
Price
117.41
Change %
-4.65%
ProShares Ultra Nasdaq Biotechnology seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.